GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GRAL GRAIL, Inc.

Post-Mkt 08-07 19:10:02 EDT

69.48

+6.08

+9.59%

盘后69.27

-0.21-0.30%

18:58 EDT

High69.54	Low63.40	Vol1.64M
Open65.00	D1 Closing63.40	Amplitude9.68%
Mkt Cap3.10B	Tradable Cap2.82B	Total Shares44.67M
T/O111.05M	T/O Rate4.04%	Tradable Shares40.64M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":69.48,"timestamp":1786132800000,"preClose":63.4,"halted":0,"volume":1643847,"hourTrading":{"tag":"盘后","latestPrice":69.27,"preClose":69.48,"latestTime":"18:58 EDT","volume":2918,"amount":202326.56238000002,"timestamp":1786143501410,"change":-0.21,"changeRate":-0.003022,"amplitude":0.014105},"delay":0,"changeRate":0.09589905362776034,"floatShares":40644723,"shares":44666200,"eps":-9.748709,"marketStatus":"Post-Mkt","change":6.08,"latestTime":"08-07 19:10:02 EDT","open":65,"high":69.54,"low":63.4,"amount":111051119.70860998,"amplitude":0.096845,"askPrice":70.03,"askSize":1,"bidPrice":62.89,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-9.748709,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786147200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":63.4,"preHourTrading":{"tag":"盘前","latestPrice":64.61,"preClose":63.4,"latestTime":"09:29 EDT","volume":948,"amount":61173.90912,"timestamp":1786109399999,"change":1.21,"changeRate":0.019085,"amplitude":0.014984},"postHourTrading":{"tag":"盘后","latestPrice":69.27,"preClose":69.48,"latestTime":"18:58 EDT","volume":2918,"amount":202326.56238000002,"timestamp":1786143501410,"change":-0.21,"changeRate":-0.003022,"amplitude":0.014105},"volumeRatio":2.131756,"optionData":{"bulkOrders":[{"symbol":"GRAL","call":false,"expireDate":1789704000000,"strike":"55.0","timestamp":1786112039223,"price":1.35,"volume":1995,"amount":269325,"type":"-"},{"symbol":"GRAL","call":false,"expireDate":1792123200000,"strike":"55.0","timestamp":1786112039223,"price":3.95,"volume":1995,"amount":788025,"type":"-"}]},"impliedVol":0.76,"impliedVolPercentile":0.0199},"requestUrl":"/m/hq/s/GRAL/tweets","defaultTab":"tweets","newsList":[{"id":"2657164270","title":"GRAIL Says FDA Advisory Committee to Review GRAIL Galleri PMA Application on September 23","url":"https://stock-news.laohu8.com/highlight/detail?id=2657164270","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657164270?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:24","pubTimestamp":1786116273,"startTime":"0","endTime":"0","summary":"BRIEF-GRAIL Says FDA Advisory Committee To Review GRAIL Galleri PMA Application On September 23Aug 7 (Reuters)-GRAIL IncGRAL.O:GRAIL ANNOUNCES FDA ADVISORY COMMITTEE MEETING TO REVIEW PREMARKET APPROV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA5R0PZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642458","title":"US FDA to Hold Advisory Meeting to Review Grail's Multi-Cancer Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642458?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115453,"startTime":"0","endTime":"0","summary":"US FDA to hold advisory meeting to review Grail's multi-cancer testAug 7 (Reuters)-GrailGRAL.Osaid on Friday the US FDA plans to hold a meeting of outside experts to review its multi-cancer screening test Galleri in September.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4N4441AD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4129","FBT","BK4588","XBIX","GRAL","SBIO","BBH","IBRN","PMA","BBP","PBE","BK4139","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642190","title":"Grail Says FDA Advisory Panel Meets Sept. 23 on Galleri Test PMA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642190","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642190?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:05","pubTimestamp":1786115129,"startTime":"0","endTime":"0","summary":"Grail says FDA advisory panel meets Sept. 23 on Galleri test PMA reviewGrail faces an FDA advisory committee review on Sept. 23, 2026 for its Galleri multi-cancer early detection blood test PMA.The PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL3BHQfs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657194642","title":"Grail Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2657194642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657194642?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:05","pubTimestamp":1786115100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA5R0PZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657658221","title":"Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657658221?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:01","pubTimestamp":1786028513,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on GRAIL Inc (GRAL) and Lineage, Inc. (LINE). GRAIL Inc (GRAL) In a report r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4224","NA","GRAL","BK4139","LINE","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657637857","title":"Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and SanDisk Corp (SNDK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657637857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657637857?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:40","pubTimestamp":1786023613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on GRAIL Inc (GRAL) and SanDisk Corp (SNDK) with bullish sentim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-sandisk-corp-sndk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-sandisk-corp-sndk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNAV","FSMD","QQQG","SCHM","BK4139","SNDC","TMSL","SNDQ","COWG","OPTZ","GRAL","LU0054578231.USD","LU2290526834.HKD","PTF","FCUS","LU2360107168.USD","SCHA","SNDG","SNXX","SNDK","BK4170","SNDU","LU0963586101.USD","LU2543165471.USD","LU1861215975.USD","LU2063271972.USD","DISK","LU1861220033.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657763465","title":"Grail Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657763465","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657763465?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:01","pubTimestamp":1785963711,"startTime":"0","endTime":"0","summary":"Grail Inc reports results for the quarter ended June 30 - Earnings SummaryGrail IncGRAL.OQreported a quarterly adjusted loss of $2.56 per share for the quarter ended June 30, higher than the same quar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520204","title":"GRAIL Q2 EPS $(2.56) Beats $(2.62) Estimate, Sales $44.687M Beat $42.760M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520204","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520204?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:14","pubTimestamp":1785960859,"startTime":"0","endTime":"0","summary":"GRAIL (NASDAQ:GRAL) reported quarterly losses of $(2.56) per share which beat the analyst consensus estimate of $(2.62) by 1.92 percent. This is a 19.5 percent increase over losses of $(3.18) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60970657/grail-q2-eps-2-56-beats-2-62-estimate-sales-44-687m-beat-42-760m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GRAIL Q2 EPS $(2.56) Beats $(2.62) Estimate, Sales $44.687M Beat $42.760M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657209515","title":"Grail Q2 Revenue Rises 26%, Net Loss Narrows 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657209515","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657209515?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:11","pubTimestamp":1785960674,"startTime":"0","endTime":"0","summary":"Grail Q2 revenue rises 26%, net loss narrows 3%OverviewUS cancer screening test maker's Q2 revenue rose 26% yr/yr, Galleri test revenue up 24%Net loss for Q2 narrowed 3% from prior yearCompany complet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOPH","BK4539","BK4121","BK4167","GRAL","PSNL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657527632","title":"Grail Inc Q2 Net Income USD -110.247 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527632?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:02","pubTimestamp":1785960120,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXJSP6G7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656858895","title":"Grail Inc Expected to Post a Loss of $2.65 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656858895","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656858895?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:49","pubTimestamp":1785800949,"startTime":"0","endTime":"0","summary":"Grail Inc <GRAL.OQ> expected to post a loss of $2.65 a share - Earnings PreviewGrail IncGRAL.OQGRAL.Ois expected to  show a rise in quarterly revenue when it reports  results on August 5 for the perio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4402SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383770","title":"Grail Management to Present at Canaccord Genuity Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383770?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:07","pubTimestamp":1785442029,"startTime":"0","endTime":"0","summary":"Grail management to present at Canaccord Genuity Growth ConferenceGrail will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on Aug. 11 at 10:00 a.m. ET.Disclaimer:This news b","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL37260p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655815418","title":"Grail to Report Q2 2026 Results After Market Close, Host Webcast Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655815418","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655815418?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:02","pubTimestamp":1785355353,"startTime":"0","endTime":"0","summary":"Grail to report Q2 2026 results after market close, host webcast callGrail will report second-quarter 2026 financial results on Aug. 5, 2026, following the market close.Management will host a webcast,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4whwm4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651442688","title":"Priority Health Collaborates with Grail as the First Michigan Health Plan to Offer the Galleri® Multi-cancer Early Detection Blood Test to Employer Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2651442688","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651442688?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:00","pubTimestamp":1784206805,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA6NTCLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651645285","title":"Grail Inc : Mizuho Raises Target Price to $65 from $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2651645285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651645285?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:37","pubTimestamp":1784111876,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650451974","title":"Cancer Blood Screen Spac's Merger is Delayed by Test's Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2650451974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650451974?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:24","pubTimestamp":1783628640,"startTime":"0","endTime":"0","summary":"Call Thursday's cancer test results mixed.Thursday was the day set for shareholders to approve the merger of special-purpose acquisition company Perceptive Capital Solutions with cancer screening firm","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","EKG","PTH","GDOC","GNOM","LFSC","HELX","BK4588","BK4585","BK4196","LU0889565916.HKD","BK4551","GRAL","LU0320765992.SGD","BK4139","LU0109394709.USD","PCSC","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649564670","title":"GRAIL (GRAL) Could Be 5% Overvalued Following Trial Miss And Class Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2649564670","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649564670?lang=en_us&edition=fundamental","pubTime":"2026-07-07 08:32","pubTimestamp":1783384358,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) stock has been in focus after the company disclosed that its NHS-Galleri trial did not meet the primary endpoint in reducing late stage cancers, triggering sharp losses and a wave of securities class action lawsuits.\nSee our latest analysis for GRAIL.\nSince that disclosure and the resulting securities class actions, GRAIL’s share price has seen a 14.95% 1 month share price return and a 40.28% 3 month share price return. The 1 year total shareholder return is 53.73%, suggesting...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-following-trial-miss-and-cl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-following-trial-miss-and-cl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648524361","title":"When Multi-cancer Blood Screens Could Finally Take Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2648524361","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648524361?lang=en_us&edition=fundamental","pubTime":"2026-07-02 06:02","pubTimestamp":1782943320,"startTime":"0","endTime":"0","summary":"Investors have waited with varying levels of patience for multi-cancer screening tests to lift off toward a targeted $30 billion to $50 billion in annual volume. Sales this year from the blood tests w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","LU0109394709.USD","BK4551","IE00B2B36J28.USD","LU0114720955.EUR","NTRA","LU1989763427.SGD","LU0963586101.USD","GRAL","LU0868494617.USD","LU1691799644.USD","BK4585","LU2065169927.USD","LU1023059063.AUD","BK4196","LU0882574055.USD","LU1061106388.HKD","BK4504","SGXZ41872573.SGD","IE0009355771.USD","GH","LU0266013472.USD","LU0289739699.SGD","LU2133065610.SGD","LU2324357040.USD","LU1989763690.USD","LU0058720904.USD","LU2264538146.SGD","BK4592","BK4535","LU1721429741.USD","LU2237957811.SGD","LU2065171311.SGD","ABT","BK4566","SG9999002232.USD","LU0122379950.USD","LU0345770993.USD","IE00BJT1NW94.SGD","BK4581","LU2211815571.USD","LU0170899867.USD","LU0889565916.HKD","IE0002141913.USD","LU2065171402.SGD","BK4139","SG9999004303.SGD","LU2089984988.USD","LU1914381329.SGD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646580378","title":"Grail Partners with Samsung C&T to Commercialize Galleri Cancer Test in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2646580378","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646580378?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:13","pubTimestamp":1782393226,"startTime":"0","endTime":"0","summary":"Grail partners with Samsung C&T to commercialize Galleri cancer test in South KoreaGrail entered a planned commercial collaboration with Samsung C&T to launch the Galleri multi-cancer early detection ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL8qJ9H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com;investors.grail.com","stockEarnings":[{"period":"1week","weight":-0.1088},{"period":"1month","weight":-0.0784},{"period":"3month","weight":0.0286},{"period":"6month","weight":-0.3664},{"period":"1year","weight":0.9166},{"period":"ytd","weight":-0.2593}],"compareEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":0.0279},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.1129},{"period":"1year","weight":0.2146},{"period":"ytd","weight":0.1271}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GRAIL, Inc.(GRAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GRAIL, Inc.(GRAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}